Economists have ‘never seen anything like this’, and ‘challenges are on a greater scale’ than ever before, so how can China ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its ...

The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...

The Food and Drug Administration (FDA) today released guidance that is effective immediately for compounding certain parenteral drug products in response to the effects of recent hurricanes, including ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

Retirees are still paying off loans for degrees that never led to jobs that paid enough to extinguish the debt.

The magic of compounding interest Melissa Leong shows why the earlier you save, the better it is. Calculations courtesy of ...

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

Compounding pharmacies sued the FDA after its declaration, bringing an end to the sale of the "copycat" drugs they provide. Meanwhile, as demand soars for weight loss drugs, WeightWatchers eyes ...

A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...